Meeder Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $622K | Buy |
17,259
+4,853
| +39% | +$175K | 0.03% | 337 |
|
|
2025
Q1 | $386K | Buy |
12,406
+995
| +9% | +$31K | 0.02% | 406 |
|
|
2024
Q4 | $291K | Buy |
11,411
+4,201
| +58% | +$107K | 0.02% | 459 |
|
|
2024
Q3 | $204K | Sell |
7,210
-1,013
| -12% | -$28.7K | 0.01% | 526 |
|
|
2024
Q2 | $217K | Buy |
8,223
+926
| +13% | +$24.4K | 0.02% | 476 |
|
|
2024
Q1 | $222K | Sell |
7,297
-185
| -2% | -$5.62K | 0.02% | 411 |
|
|
2023
Q4 | $210K | Buy |
+7,482
| New | +$210K | 0.02% | 405 |
|